Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 308295, 9 pages
http://dx.doi.org/10.1155/2014/308295
Research Article

Effects of β-Adrenoceptor Subtypes on Cardiac Function in Myocardial Infarction Rats Exposed to Fine Particulate Matter (PM2.5)

1First Hospital of Shanxi Medical University, Taiyuan 030001, China
2The Affiliated Dayi Hospital of Shanxi Medical University, Taiyuan 030032, China

Received 31 May 2014; Accepted 5 June 2014; Published 12 August 2014

Academic Editor: Jason Ng

Copyright © 2014 Yuping Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ma̧czewski and U. Mackiewicz, “Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart,” Cardiovascular Research, vol. 79, no. 1, pp. 42–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Singh, C. Communal, D. B. Sawyer, and W. S. Colucci, “Adrenergic regulation of myocardial apoptosis,” Cardiovascular Research, vol. 45, no. 3, pp. 713–719, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Khan, S. Mohsin, D. Avitabile et al., “β-adrenergic regulation of cardiac progenitor cell death versus survival and proliferation,” Circulation Research, vol. 112, no. 3, pp. 476–486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Di Lisa, N. Kaludercic, and N. Paolocci, “β2-adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another “radical” road to heart failure?” British Journal of Pharmacology, vol. 162, no. 5, pp. 1009–1011, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Zhang, J. Xiang, X. Wang et al., “β2-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats,” British Journal of Pharmacology, vol. 160, no. 6, pp. 1561–1572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Ahmet, C. Morrell, E. G. Lakatta, and M. I. Talan, “Therapeutic efficacy of a combination of a β1-adrenoreceptor (AR) blocker and β2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a β1-AR blocker plus angiotensin-converting enzyme inhibitor,” Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 1, pp. 178–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Ahmet, M. Krawczyk, W. Zhu et al., “Cardioprotective and survival benefits of long-term combined therapy with β2 adrenoreceptor (AR) agonist and β1 AR blocker in dilated cardiomyopathy postmyocardial infarction,” The Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 2, pp. 491–499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Molenaar, T. Christ, U. Ravens, and A. Kaumann, “Carvedilol blocks β2- more than β1- adrenoceptors in human heart,” Cardiovascular Research, vol. 69, no. 1, pp. 128–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Tonne and P. Wilkinson, “Long-term exposure to air pollution is associated with survival following acute coronary syndrome,” European Heart Journal, vol. 34, no. 17, pp. 1306–1311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Ying, P. Yue, X. Xu et al., “Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1540–H1550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Madrigano, I. Kloog, R. Goldberg, B. A. Coull, M. A. Mittleman, and J. Schwartz, “Long-term exposure to PM2.5 and incidence of acute myocardial infarction,” Environmental Health Perspectives, vol. 121, no. 2, pp. 192–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Pope III, R. T. Burnett, M. J. Thun et al., “Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution,” The Journal of the American Medical Association, vol. 287, no. 9, pp. 1132–1141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Hoek, R. M. Krishnan, R. Beelen et al., “Long-term air pollution exposure and cardio-respiratory mortality: a review,” Environmental Health, vol. 12, no. 1, article 43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Franchini and P. M. Mannucci, “Particulate air pollution and cardiovascular risk: short-term and long-term effects,” Seminars in Thrombosis and Hemostasis, vol. 35, no. 7, pp. 665–670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. A. Pope III, J. B. Muhlestein, H. T. May, D. G. Renlund, J. L. Anderson, and B. D. Horne, “Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution,” Circulation, vol. 114, no. 23, pp. 2443–2448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. C. Hong, J. T. Lee, H. Kim, and H. J. Kwon, “Air pollution: a new risk factor in ischemic stroke mortality,” Stroke, vol. 33, no. 9, pp. 2165–2169, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. Wellenius, J. Schwartz, and M. A. Mittleman, “Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries,” Stroke, vol. 36, no. 12, pp. 2549–2553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Pekkanen, A. Peters, G. Hoek et al., “Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the exposure and risk assessment for fine and ultrafine particles in ambient air (ULTRA) study,” Circulation, vol. 106, no. 8, pp. 933–938, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. D. R. Gold, A. A. Litonjua, A. Zanobetti et al., “Air pollution and ST-segment depression in elderly subjects,” Environmental Health Perspectives, vol. 113, no. 7, pp. 883–887, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Peters, A. Döring, H. Wichmann, and W. Koenig, “Increased plasma viscosity during an air pollution episode: a link to mortality?” The Lancet, vol. 349, no. 9065, pp. 1582–1587, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Salvi, A. Blomberg, B. Rudell et al., “Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 3, pp. 702–709, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Rückerl, A. Ibald-Mulli, W. Koenig et al., “Air pollution and markers of inflammation and coagulation in patients with coronary heart disease,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 4, pp. 432–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. C. A. Pope III, R. L. Verrier, E. G. Lovett et al., “Heart rate variability associated with particulate air pollution,” The American Heart Journal, vol. 138, part 1, no. 5, pp. 890–899, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. D. R. Gold, A. Litonjua, J. Schwartz et al., “Ambient pollution and heart rate variability,” Circulation, vol. 101, no. 11, pp. 1267–1273, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Li, F. Cao, F. Liu, X. Bai, and Y. Lü, “Effects of Shexiangbaoxin pills on the expression of cardiac α1- and β-adrenergic receptor subtypes in rat hearts with heart failure induced by myocardial infarction,” Chinese Medical Journal, vol. 125, no. 9, pp. 1556–1562, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Wu, X. Yin, C. Wijaya, M. Huang, and B. K. McConnell, “Acute myocardial infarction in rats,” Journal of Visualized Experiments, no. 48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Emmerechts, E. Alfaro-Moreno, B. M. Vanaudenaerde, B. Nemery, and M. F. Hoylaerts, “Short-term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice,” Journal of Thrombosis and Haemostasis, vol. 8, no. 12, pp. 2651–2661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. G. Wallenborn, J. K. McGee, M. C. Schladweiler, A. D. Ledbetter, and U. P. Kodavanti, “Systemic translocation of particulate matter-associated metals following a single intratracheal instillation in rats,” Toxicological Sciences, vol. 98, no. 1, pp. 231–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. E. Lindley, D. W. Infanger, M. Rishniw et al., “Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction,” American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 296, no. 1, pp. R1–R8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. vanHoose, Y. Sawers, R. Loganathan et al., “Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat,” Cardiovascular Diabetology, vol. 9, article 56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zhang, J. Lu, D. Chen et al., “Myocardial autophagy variation during acute myocardial infarction in rats: the effects of carvedilol,” Chinese Medical Journal, vol. 122, no. 19, pp. 2372–2379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Qin, M. Simeone, and R. Patel, “Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction,” Free Radical Biology and Medicine, vol. 43, no. 2, pp. 271–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Tao, E. Gao, A. Hu et al., “Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress,” British Journal of Pharmacology, vol. 149, no. 3, pp. 311–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Qin, S. Lennon-Edwards, S. Lancel et al., “Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and-independent phases of myocardial remodeling and prevents the progression to overt heart failure in Gαq-overexpressing transgenic mice,” Circulation: Heart Failure, vol. 3, no. 2, pp. 306–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Wu, Y. Cai, Z. Xin, X. Wang, and S. Yan, “Pure alumina bearings with cementless stems versus sandwich bearings with cemented stems in total hip arthroplasty,” Chinese Medical Journal, vol. 125, no. 2, pp. 244–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Luo, Y. Bi, and Y. Xu, “Effects of metoprolol on β1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure,” Chinese Medical Journal, vol. 120, no. 19, pp. 1720–1723, 2007. View at Google Scholar · View at Scopus
  37. W. N. Liu, K. L. Fu, H. Y. Gao et al., “β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis,” PLoS ONE, vol. 7, no. 7, Article ID e37659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. B. C. do Nascimento, S. B. Pereira, G. S. Ribeiro, and E. T. Mesquita, “Beta1-adrenergic receptor polymorphisms associated with atrial fibrillation in systolic heart failure,” Arquivos Brasileiros de Cardiologia, vol. 98, no. 5, pp. 384–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. C. C. Okafor, C. Perreault-Micale, R. J. Hajjar et al., “Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure,” BMC Physiology, vol. 3, no. 1, article 6, 2003. View at Google Scholar · View at Scopus
  40. G. Condorelli, C. Morisco, G. Stassi et al., “Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat,” Circulation, vol. 99, no. 23, pp. 3071–3078, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. N. S. Rehsia and N. S. Dhalla, “Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure,” Experimental and Clinical Cardiology, vol. 15, no. 4, pp. e86–e95, 2010. View at Google Scholar · View at Scopus
  42. I. Ahmet, E. G. Lakatta, and M. I. Talan, “Pharmacological stimulation of β2-adrenergic receptors (β2AR) enhances therapeutic effectiveness of β1AR blockade in rodent dilated ischemic cardiomyopathy,” Heart Failure Reviews, vol. 10, no. 4, pp. 289–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. A. Pope III, R. T. Burnett, G. D. Thurston et al., “Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease,” Circulation, vol. 109, no. 1, pp. 71–77, 2004. View at Publisher · View at Google Scholar · View at Scopus